Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00278473 · ClinicalTrials.gov registry record · NA

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults

A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT00278473 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 88 participants, below the 351-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00278473, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with attention deficit hyperactivity disorder (ADHD).

Interventions

  • BEHAVIORAL Supportive Therapy
  • BEHAVIORAL Meta-Cognitive Therapy

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2005-05
Est. Completion 2008-10
Phase NA

What the Registry Record Tells You About NCT00278473

The ClinicalTrials.gov registry entry for NCT00278473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 351-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (75% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 2 interventions - of which Supportive Therapy is the first listed.

NCT00278473 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00278473 about?

NCT00278473 is a clinical study titled "Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults". This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with attention deficit hyperactivity disorder (ADHD).

What is the current status of trial NCT00278473?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2005-05. Estimated completion is 2008-10.

What conditions does trial NCT00278473 study?

This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.

What interventions are being tested in trial NCT00278473?

The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Meta-Cognitive Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00278473?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00278473 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Disorder With Hyperactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.